Mark J Powell PhD

Mark J Powell PhD has extensive work experience in the field of biotechnology and medical research. Mark J is currently working as a Principal Scientist at PsiOxus Therapeutics Ltd since January 2021. Prior to this, they served as a Medical Writer at Fishawack Health from June 2020 to January 2021.

From September 2015 to May 2020, Mark worked at IMMUNOCORE LIMITED as a Biomarkers specialist. During this time, they played a key role in developing and managing biomarker assays to support small molecule and antibody programs.

Before their tenure at IMMUNOCORE LIMITED, Mark served as a Senior Scientist at UCB Celltech from April 2007 to August 2015. In this role, they had project leadership responsibilities and managed a team while working on immunology and oncology projects. Mark J made significant contributions to the development of cellular and biomarker assays, including the creation of a whole blood biomarker assay that supported the understanding of pharmacokinetics/pharmacodynamics and human dose prediction.

Prior to joining UCB Celltech, Mark worked as a Senior Scientist at Rigel from September 2001 to February 2007. Mark J also gained valuable experience as a Post-Doctoral Fellow at Novartis Pharmaceuticals from July 1998 to September 2001.

Overall, Mark J Powell PhD has a strong background in biotechnology and medical research, with expertise in biomarker development, project leadership, and immunology/oncology.

Mark J Powell PhD completed their Bachelor of Science Honors (First Class) degree in Biochemistry at the University of Bath. Mark J then pursued further studies and obtained their PhD in Immunology from the University of Oxford, which they completed from 1994 to 1998.